Free Trial

180 Life Sciences (ATNF) Stock Price, News & Analysis

180 Life Sciences logo
$3.00 +0.87 (+40.85%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$2.80 -0.20 (-6.67%)
As of 07/25/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About 180 Life Sciences Stock (NASDAQ:ATNF)

Key Stats

Today's Range
$2.33
$3.41
50-Day Range
$0.80
$3.00
52-Week Range
$0.66
$17.75
Volume
16.48 million shs
Average Volume
4.96 million shs
Market Capitalization
$18.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

180 Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
20th Percentile Overall Score

ATNF MarketRank™: 

180 Life Sciences scored higher than 20% of companies evaluated by MarketBeat, and ranked 857th out of 936 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for 180 Life Sciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 180 Life Sciences is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 180 Life Sciences is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    180 Life Sciences has a P/B Ratio of 3.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about 180 Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    2.23% of the float of 180 Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    180 Life Sciences has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 180 Life Sciences has recently increased by 66.75%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    180 Life Sciences does not currently pay a dividend.

  • Dividend Growth

    180 Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.23% of the float of 180 Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    180 Life Sciences has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 180 Life Sciences has recently increased by 66.75%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    180 Life Sciences has a news sentiment score of 1.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.09 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for 180 Life Sciences this week, compared to 0 articles on an average week.
  • Search Interest

    7 people have searched for ATNF on MarketBeat in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added 180 Life Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, 180 Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    38.20% of the stock of 180 Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.07% of the stock of 180 Life Sciences is held by institutions.

  • Read more about 180 Life Sciences' insider trading history.
Receive ATNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

ATNF Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
180 Life Sciences prices $2.9M registered direct offering at $2.41 per share
180 Life Sciences CFO Omar Jimenez Resigns
180 Life Sciences files to sell 1.9M shares of common stock for holders
See More Headlines

ATNF Stock Analysis - Frequently Asked Questions

180 Life Sciences' stock was trading at $1.82 at the beginning of the year. Since then, ATNF shares have increased by 64.8% and is now trading at $3.00.

180 Life Sciences Corp. (NASDAQ:ATNF) announced its quarterly earnings results on Wednesday, July, 23rd. The company reported ($0.30) earnings per share for the quarter.

180 Life Sciences's stock reverse split on Wednesday, February 28th 2024.The 1-19 reverse split was announced on Wednesday, February 28th 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 180 Life Sciences investors own include Meta Platforms (META), NIO (NIO), Enterprise Products Partners (EPD), HubSpot (HUBS), Netflix (NFLX), Plug Power (PLUG).

Company Calendar

Last Earnings
7/23/2025
Today
7/27/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATNF
CIK
1690080
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.17 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.25%
Return on Assets
-80.77%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.58
Quick Ratio
1.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.89 per share
Price / Book
3.37

Miscellaneous

Outstanding Shares
6,040,000
Free Float
3,732,000
Market Cap
$18.12 million
Optionable
No Data
Beta
0.22
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:ATNF) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners